Athira pharma to participate in upcoming may investor conferences

Bothell, wash., may 08, 2023 (globe newswire) -- athira pharma, inc. (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that it will participate in the following upcoming investor conferences:
ATHA Ratings Summary
ATHA Quant Ranking